American Century Companies’s Madrigal Pharmaceuticals MDGL Stock Holding History

American Century Companies's MDGL Position: Q2 2026 in Review

American Century Companies reduced its Madrigal Pharmaceuticals (MDGL) stake by 39% in Q2 2026, selling an estimated $33.1M and leaving 99,396 shares worth $53.4M. The position accounts for 0.02% of the portfolio, ranked #836.

American Century Companies first reported a position in MDGL in Q2 2018 and has held it in 15 quarters since. The position peaked at $108M in Q4 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

• American Century Companies held 99,396 shares of Madrigal Pharmaceuticals worth $53.4M as of Q2 2026.
• American Century Companies sold 64,537 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $33.1M.
• Madrigal Pharmaceuticals made up 0.02% of American Century Companies's portfolio in Q2 2026, its #836 holding.
• American Century Companies first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 15 quarters since.
• American Century Companies's Madrigal Pharmaceuticals position peaked at $108M in Q4 2025.
• 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.